Evercore Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
+556
New +$206K ﹤0.01% 390
2026
Q1
Sell
-579
Closed -$203K 425
2025
Q4
$203K Buy
+579
New +$196K ﹤0.01% 393
2025
Q3
Sell
-596
Closed -$232K 418
2025
Q2
$232K Hold
596
﹤0.01% 373
2025
Q1
$259K Sell
596
-19
-3% -$7.63K ﹤0.01% 360
2024
Q4
$227K Sell
615
-101
-14% -$42.3K ﹤0.01% 383
2024
Q3
$372K Hold
716
0.01% 313
2024
Q2
$388K Sell
716
-23
-3% -$12.2K 0.01% 306
2024
Q1
$383K Sell
739
-14
-2% -$6.96K 0.01% 311
2023
Q4
$355K Buy
753
+12
+2% +$5.55K 0.01% 312
2023
Q3
$323K Sell
741
-58
-7% -$26.3K 0.01% 309
2023
Q2
$355K Sell
799
-6
-0.7% -$2.77K 0.01% 310
2023
Q1
$370K Sell
805
-12
-1% -$5.71K 0.01% 300
2022
Q4
$419K Sell
817
-73
-8% -$37.1K 0.01% 288
2022
Q3
$404K Sell
890
-72
-7% -$34.5K 0.01% 276
2022
Q2
$464K Hold
962
0.01% 263
2022
Q1
$473K Sell
962
-88
-8% -$40.2K 0.01% 291
2021
Q4
$487K Sell
1,050
-30
-3% -$12.6K 0.01% 287
2021
Q3
$403K Hold
1,080
0.01% 316
2021
Q2
$412K Sell
1,080
-541
-33% -$207K 0.01% 315
2021
Q1
$582K Sell
1,621
-25
-2% -$8.04K 0.01% 277
2020
Q4
$529K Buy
1,646
+187
+13% +$57.4K 0.01% 281
2020
Q3
$392K Buy
1,459
+13
+0.9% +$3.5K 0.01% 288
2020
Q2
$380K Hold
1,446
0.01% 287
2020
Q1
$328K Buy
1,446
+3
+0.2% +$818 0.01% 283
2019
Q4
$436K Sell
1,443
-31
-2% -$8.53K 0.01% 295
2019
Q3
$354K Sell
1,474
-30
-2% -$8.22K 0.01% 309
2019
Q2
$424K Buy
1,504
+2
+0.1% +$546 0.01% 293
2019
Q1
$431K Buy
1,502
+20
+1% +$5.78K 0.01% 287
2018
Q4
$389K Sell
1,482
-496
-25% -$136K 0.01% 276
2018
Q3
$542K Buy
1,978
+2
+0.1% +$519 0.02% 270
2018
Q2
$470K Sell
1,976
-55
-3% -$12.7K 0.02% 276
2018
Q1
$446K Sell
2,031
-120
-6% -$28.2K 0.02% 257
2017
Q4
$484K Hold
2,151
0.02% 260
2017
Q3
$408K Hold
2,151
0.02% 274
2017
Q2
$405K Sell
2,151
-50
-2% -$8.98K 0.02% 280
2017
Q1
$364K Sell
2,201
-218
-9% -$34.7K 0.01% 298
2016
Q4
$348K Sell
2,419
-340
-12% -$45.5K 0.01% 289
2016
Q3
$346K Sell
2,759
-49
-2% -$6.33K 0.01% 294
2016
Q2
$369K Buy
2,808
+101
+4% +$13.8K 0.02% 278
2016
Q1
$376K Hold
2,707
0.02% 279
2015
Q4
$377K Buy
2,707
+581
+27% +$80K 0.02% 285
2015
Q3
$298K Buy
2,126
+152
+8% +$22.8K 0.01% 329
2015
Q2
$324K Hold
1,974
0.01% 340
2015
Q1
$304K Buy
1,974
+30
+2% +$4.27K 0.01% 349
2014
Q4
$245K Sell
1,944
-276
-12% -$34.1K 0.01% 326
2014
Q3
$266K Buy
2,220
+1,000
+82% +$115K 0.01% 351
2014
Q2
$131K Hold
1,220
0.01% 468
2014
Q1
$121K Hold
1,220
0.01% 451
2013
Q4
$113K Sell
1,220
-58
-5% -$5.15K 0.01% 439
2013
Q3
$106K Buy
1,278
+58
+5% +$4.97K 0.01% 479
2013
Q2
$100K Buy
+1,220
New +$91.3K 0.01% 491

Other funds holding ELV

Evercore Wealth Management's ELV Position: Q2 2026 in Review

Evercore Wealth Management opened a new position in Elevance Health (ELV) in Q2 2026: 556 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #390 among its holdings. This is a return to the name: Evercore Wealth Management previously reported a position in ELV as recently as Q4 2025.

Evercore Wealth Management first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $582K in Q1 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Evercore Wealth Management held 556 shares of Elevance Health worth $215K as of Q2 2026.
  • Elevance Health was a new Evercore Wealth Management position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #390 holding.
  • Evercore Wealth Management first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Evercore Wealth Management's Elevance Health position peaked at $582K in Q1 2021.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.